Aggressive Versus Standard Periprocedural Hydration With Lactated Ringer's Solution for the Prevention of Post-ERCP Pancreatitis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
In brief
Aggressive hydration cut post-ERCP pancreatitis from 13.6% to 5.2%
Across nine trials involving 2,060 adults, aggressive hydration with lactated Ringer's solution lowered pancreatitis after ERCP compared with standard hydration. The evidence was low certainty, and whether extra fluids help patients already receiving rectal anti-inflammatory drugs remains unknown; only six fluid-overload events were reported, too few to assess safety reliably.
- Journal
- Journal of gastroenterology and hepatology (Q1)
- Published
- 13 November 2026
- Study design
- Systematic review / meta-analysis of RCTs
- Evidence level
- Level 1, High (CEBM 1a)
- Authors
- Faisal A Al-Harbi, Ghala Abdullah Alnaim, Roaa Mohammed Alharbi, Shura Fahad Alsharekh, Hind Mohammed Alzaidan, Deem Ahmad Aldabibi, et al.
- PMID
- 43031376
- DOI
- 10.1111/jgh.70877
Why clinicians should know about it
- Picked for Gastroenterology (paper of the day, 16 November 2026): Meta-analysis of randomized trials addressing post-ERCP pancreatitis prevention
Abstract
INTRODUCTION: Post-ERCP pancreatitis (PEP) remains the most frequent complication of endoscopic retrograde cholangiopancreatography (ERCP). Earlier syntheses pooled trials with different fluids in each arm, so the contribution of volume could not be separated from that of fluid composition. METHODS: PubMed, Web of Science, and Scopus were searched from inception to June 15, 2026 (PROSPERO CRD420261453240). We included randomized controlled trials (RCTs) of aggressive versus standard periprocedural hydration in adults undergoing first-time ERCP, using lactated Ringer's solution (LRS) in both arms. Risk ratios (RR) and mean differences (MD) were pooled with random-effects models; bias was assessed with Cochrane RoB 2 and certainty of evidence with Grading of Recommendations Assessment, Development and Evaluation (GRADE). RESULTS: Nine RCTs (2060 patients) were included. Aggressive hydration reduced overall PEP from 13.6% to 5.2% (RR 0.39; 95% CI 0.27-0.56; low certainty). Moderate-to-severe PEP (RR 0.37; 95% CI 0.17-0.82), hyperamylasemia (RR 0.61; 95% CI 0.48-0.79), and abdominal pain (RR 0.46; 95% CI 0.26-0.82) were also reduced, all with low or very low certainty; the pooled difference in hospital stay (MD - 0.77 days; 95% CI -1.40 to -0.15; I2 = 92.7%) was uninterpretable owing to extreme heterogeneity. Fluid overload was too infrequent to be informative (6 events). The overall PEP estimate was robust to excluding high risk of bias and 2026 trials but attenuated when restricted to the three low-risk-of-bias trials (RR 0.52; 95% CI 0.26-1.03). CONCLUSIONS: Aggressive periprocedural LRS may reduce overall PEP when rectal NSAIDs are not used (low certainty). Any added benefit in patients already receiving rectal NSAIDs remains unproven.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.